Article > GSK/HGS' Benlysta gets European OK for lupus | Veille Pharma | Scoop.it
GlaxoSmithKline and Human Genome Sciences' lupus drug Benlysta, which is widely expected to become a blockbuster, has been given the thumbs-up by regulators in Europe.